Priorities for CMV vaccine development

Philip R. Krause, Stephanie R. Bialek, Suresh B. Boppana, Paul D. Griffiths, Catherine A. Laughlin, Per Ljungman, Edward S. Mocarski, Robert F. Pass, Jennifer S. Read, Mark R. Schleiss, Stanley A. Plotkin

Research output: Contribution to journal › Review article › peer-review

131 Scopus citations

Fingerprint

Dive into the research topics of 'Priorities for CMV vaccine development'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology